|
gptkbp:instanceOf
|
gptkb:drug
chelating agent
|
|
gptkbp:approvedBy
|
1940s
|
|
gptkbp:ATCCode
|
V03AB03
|
|
gptkbp:CASNumber
|
59-52-9
|
|
gptkbp:chemicalFormula
|
C3H8OS2
|
|
gptkbp:contraindication
|
peanut allergy
|
|
gptkbp:developedBy
|
gptkb:World_War_II
|
|
gptkbp:discoveredBy
|
British biochemists
|
|
gptkbp:eliminationHalfLife
|
4 hours
|
|
gptkbp:excretion
|
urine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dimercaprol
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:meltingPoint
|
62 °C
|
|
gptkbp:MeSH_ID
|
gptkb:D004053
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
124.23 g/mol
|
|
gptkbp:notEffectiveAgainst
|
cadmium poisoning
iron poisoning
|
|
gptkbp:origin
|
developed as antidote to chemical warfare agent Lewisite
|
|
gptkbp:otherName
|
gptkb:BAL
gptkb:British_anti-Lewisite
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
3016
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
nausea
vomiting
hypertension
tachycardia
pain at injection site
|
|
gptkbp:solubility
|
insoluble in water
soluble in alcohol
|
|
gptkbp:UNII
|
6Q8XW47B1E
|
|
gptkbp:usedFor
|
lead poisoning
arsenic poisoning
mercury poisoning
antimony poisoning
bismuth poisoning
gold poisoning
|
|
gptkbp:bfsParent
|
gptkb:Antidotes
gptkb:Antidote
|
|
gptkbp:bfsLayer
|
5
|